APO Research
Talk to an analyst

APO RESEARCH · REPORT

ICAD (Intracranial Atherosclerotic Disease) Pathology

Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries. Stenosis (narrowing) of the artery walls in intracranial atherosclerotic disease (ICAD) develops similarly to atherosclerosis of the heart: from the buildup of plaque, also known as an atherosclerotic lesion. The product in this report is Stent and PTA balloon for Treatment of ICAD.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries. Stenosis (narrowing) of the artery walls in intracranial atherosclerotic disease (ICAD) develops similarly to atherosclerosis of the heart: from the buildup of plaque, also known as an atherosclerotic lesion. The product in this report is Stent and PTA balloon for Treatment of ICAD.

Selected research

Market Structure

Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

9 January 2026189 pages

Choose your research edition.

Industry ResearchICAD (Intracranial Atherosclerotic Disease) Pathology Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal ICAD (Intracranial Atherosclerotic Disease) Pathology Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal ICAD (Intracranial Atherosclerotic Disease) Pathology Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal ICAD (Intracranial Atherosclerotic Disease) Pathology Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries. Stenosis (narrowing) of the artery walls in intracranial atherosclerotic disease (ICAD) develops similarly to atherosclerosis of the heart: from the buildup of plaque, also known as an atherosclerotic lesion. The product in this report is Stent and PTA balloon for Treatment of ICAD.

Global ICAD (Intracranial Atherosclerotic Disease) Pathology key players include Stryker, Balt, TERUMO, MicroPort, Acandis, etc. Global top five manufacturers hold a share about 90%. Asia-Pacific is the largest market, with a share about 45%, followed by North America, with a share about 25 percent. In terms of product, Stent is the largest segment, with a share about 80%. And in terms of application, the largest application is Hospital, followed by Clinic, etc.

This report provides an overview of the global ICAD (Intracranial Atherosclerotic Disease) Pathology market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of ICAD (Intracranial Atherosclerotic Disease) Pathology and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents ICAD (Intracranial Atherosclerotic Disease) Pathology sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the ICAD (Intracranial Atherosclerotic Disease) Pathology market size, projected growth trends, production technologies, key applications, and end-use industries.

ICAD (Intracranial Atherosclerotic Disease) Pathology Segment by Company

Stryker

Balt

TERUMO

MicroPort

Acandis

ICAD (Intracranial Atherosclerotic Disease) Pathology Segment by Type

Stent

PTA Balloon

ICAD (Intracranial Atherosclerotic Disease) Pathology Segment by Application

Hospital

Clinic

Other

ICAD (Intracranial Atherosclerotic Disease) Pathology Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global ICAD (Intracranial Atherosclerotic Disease) Pathology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of ICAD (Intracranial Atherosclerotic Disease) Pathology and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of ICAD (Intracranial Atherosclerotic Disease) Pathology.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the ICAD (Intracranial Atherosclerotic Disease) Pathology market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of ICAD (Intracranial Atherosclerotic Disease) Pathology manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of ICAD (Intracranial Atherosclerotic Disease) Pathology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of ICAD (Intracranial Atherosclerotic Disease) Pathology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Trends Table 2. ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Drivers Table 3. ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Opportunities and Challenges Table 4. ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Restraints Table 5. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Manufacturers (2021-2026) Table 7. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Manufacturers (Units) & (2021-2026) Table 8. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Manufacturers Table 9. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Average Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 10. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturers, Product Type & Application Table 13. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global ICAD (Intracranial Atherosclerotic Disease) Pathology by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Stent Table 17. Major Manufacturers of PTA Balloon Table 18. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type 2021 VS 2025 VS 2032 (Units) Table 19. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2021-2026) & (Units) Table 20. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2027-2032) & (Units) Table 21. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type (2021-2026) Table 22. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type (2027-2032) Table 23. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Type 2021 VS 2025 VS 2032 (Units) Table 24. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Type (2021-2026) & (Units) Table 25. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Type (2027-2032) & (Units) Table 26. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Type (2021-2026) Table 27. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Major Manufacturers of Other Table 31. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application 2021 VS 2025 VS 2032 (Units) Table 32. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2021-2026) & (Units) Table 33. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2027-2032) & (Units) Table 34. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application (2021-2026) Table 35. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application (2027-2032) Table 36. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Application 2021 VS 2025 VS 2032 (Units) Table 37. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Application (2021-2026) & (Units) Table 38. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Application (2027-2032) & (Units) Table 39. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Application (2021-2026) Table 40. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Application (2027-2032) Table 41. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 42. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region (2021-2026) & (Units) Table 43. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Region (2021-2026) Table 44. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecasted by Region (2027-2032) & (Units) Table 45. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecasted Market Share by Region (2027-2032) Table 46. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 47. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2021-2026) & (Units) Table 48. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2027-2032) & (Units) Table 49. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 50. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2021-2026) & (Units) Table 51. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2027-2032) & (Units) Table 52. Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 53. Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2021-2026) & (Units) Table 54. Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2027-2032) & (Units) Table 55. South America, Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 56. South America, Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2021-2026) & (Units) Table 57. South America, Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2027-2032) & (Units) Table 58. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Region (2021-2026) & (US$ Million) Table 60. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Region (2027-2032) & (US$ Million) Table 61. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Region (2021-2026) Table 62. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Region (2027-2032) Table 63. Stryker Company Information Table 64. Stryker Business Overview Table 65. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio Table 67. Stryker Recent Development Table 68. Balt Company Information Table 69. Balt Business Overview Table 70. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio Table 72. Balt Recent Development Table 73. TERUMO Company Information Table 74. TERUMO Business Overview Table 75. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio Table 77. TERUMO Recent Development Table 78. MicroPort Company Information Table 79. MicroPort Business Overview Table 80. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio Table 82. MicroPort Recent Development Table 83. Acandis Company Information Table 84. Acandis Business Overview Table 85. Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio Table 87. Acandis Recent Development Table 88. Key Raw Materials Table 89. Raw Materials Key Suppliers Table 90. ICAD (Intracranial Atherosclerotic Disease) Pathology Distributors List Table 91. ICAD (Intracranial Atherosclerotic Disease) Pathology Customers List Table 92. Research Programs/Design for This Report Table 93. Authors List of This Report Table 94. Secondary Sources Table 95. Primary Sources List of Figures Figure 1. ICAD (Intracranial Atherosclerotic Disease) Pathology Product Image Figure 2. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size (2021-2032) & (US$ Million) Figure 4. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (2021-2032) & (Units) Figure 5. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Average Price (USD/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 ICAD (Intracranial Atherosclerotic Disease) Pathology Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Stent Image Figure 9. PTA Balloon Image Figure 10. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2021 VS 2025 VS 2032) & (Units) Figure 11. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type (2021-2032) Figure 13. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Type (2021 VS 2025 VS 2032) & (Units) Figure 14. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Other Image Figure 19. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2021 VS 2025 VS 2032) & (Units) Figure 20. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application (2021-2032) Figure 22. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Application (2021 VS 2025 VS 2032) & (Units) Figure 23. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Application (2021-2032) Figure 25. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2021-2032) & (Units) Figure 26. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country (2021-2032) Figure 27. U.S. ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2021-2032) & (Units) Figure 28. Canada ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2021-2032) & (Units) Figure 29. Mexico ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2021-2032) & (Units) Figure 30. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2021-2032) & (Units) Figure 31. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country (2021-2032) Figure 32. Germany ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2021-2032) & (Units) Figure 33. France ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2021-2032) & (Units) Figure 34. U.K. ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2021-2032) & (Units) Figure 35. Italy ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2021-2032) & (Units) Figure 36. Netherlands ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2021-2032) & (Units) Figure 37. Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2021-2032) & (Units) Figure 38. Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country (2021-2032) Figure 39. China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2021-2032) & (Units) Figure 40. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2021-2032) & (Units) Figure 41. South Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2021-2032) & (Units) Figure 42. Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2021-2032) & (Units) Figure 43. India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2021-2032) & (Units) Figure 44. Australia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2021-2032) & (Units) Figure 45. South America, Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2021-2032) & (Units) Figure 46. South America, Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Country (2021-2032) Figure 47. Brazil ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2021-2032) & (Units) Figure 48. South Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2021-2032) & (Units) Figure 49. Saudi Arabia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2021-2032) & (Units) Figure 50. Turkey ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2021-2032) & (Units) Figure 51. Argentina ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2021-2032) & (Units) Figure 52. UAE ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2021-2032) & (Units) Figure 53. Egypt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2021-2032) & (Units) Figure 54. Chile ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2021-2032) & (Units) Figure 55. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2021-2032) & (US$ Million) Figure 58. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2021-2032) & (US$ Million) Figure 60. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. ICAD (Intracranial Atherosclerotic Disease) Pathology Value Chain Figure 66. Manufacturing Cost Structure Figure 67. ICAD (Intracranial Atherosclerotic Disease) Pathology Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Stent
  • PTA Balloon
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Stryker
  • Balt
  • TERUMO
  • MicroPort
  • Acandis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Dynamics
  1. 2.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Trends
  2. 2.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Drivers
  3. 2.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Opportunities and Challenges
  4. 2.4 ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Restraints
3 ICAD (Intracranial Atherosclerotic Disease) Pathology Market by Manufacturers
  1. 3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Manufacturers (2021-2026)
  2. 3.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Manufacturers (2021-2026)
  3. 3.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturers, Product Type & Application
  7. 3.7 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 ICAD (Intracranial Atherosclerotic Disease) Pathology Players Market Share by Revenue in 2025
  11. 3.8.3 2025 ICAD (Intracranial Atherosclerotic Disease) Pathology Tier 1, Tier 2, and Tier 3
4 ICAD (Intracranial Atherosclerotic Disease) Pathology Market by Type
  1. 4.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Type Introduction
  2. 4.1.1 Stent
  3. 4.1.2 PTA Balloon
  4. 4.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type
  5. 4.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2021-2032)
  7. 4.2.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type (2021-2032)
  8. 4.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Type
  9. 4.3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Type (2021-2032)
  11. 4.3.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Type (2021-2032)
5 ICAD (Intracranial Atherosclerotic Disease) Pathology Market by Application
  1. 5.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application
  6. 5.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2021-2032)
  8. 5.2.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application (2021-2032)
  9. 5.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Application
  10. 5.3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Application (2021-2032)
  12. 5.3.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Application (2021-2032)
6 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region
  1. 6.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region (2021-2032)
  3. 6.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region (2021-2026)
  4. 6.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Region
  1. 7.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Region
  2. 7.1.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Region (2021-2026)
  4. 7.1.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Region (2027-2032)
  5. 7.1.4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2021-2032)
  8. 7.2.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2021-2032)
  11. 7.3.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Stryker
  2. 8.1.1 Stryker Company Information
  3. 8.1.2 Stryker Business Overview
  4. 8.1.3 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio
  6. 8.1.5 Stryker Recent Developments
  7. 8.2 Balt
  8. 8.2.1 Balt Company Information
  9. 8.2.2 Balt Business Overview
  10. 8.2.3 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio
  12. 8.2.5 Balt Recent Developments
  13. 8.3 TERUMO
  14. 8.3.1 TERUMO Company Information
  15. 8.3.2 TERUMO Business Overview
  16. 8.3.3 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio
  18. 8.3.5 TERUMO Recent Developments
  19. 8.4 MicroPort
  20. 8.4.1 MicroPort Company Information
  21. 8.4.2 MicroPort Business Overview
  22. 8.4.3 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio
  24. 8.4.5 MicroPort Recent Developments
  25. 8.5 Acandis
  26. 8.5.1 Acandis Company Information
  27. 8.5.2 Acandis Business Overview
  28. 8.5.3 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio
  30. 8.5.5 Acandis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Value Chain Analysis
  2. 9.1.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 ICAD (Intracranial Atherosclerotic Disease) Pathology Production Mode & Process
  6. 9.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Distributors
  9. 9.2.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst